Ligand Pharmaceuticals reported $-15385000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Acorda Therapeutics ACOR:US $ -46.68M 22.16M
Agenus AGEN:US $ -46.43M 1.89M
Amgen AMGN:US $ 1317M 159M
Anika Therapeutics ANIK:US $ -2.84M 0.09M
Arrowhead Research ARWR:US $ -72046000 116.41M
Baxter International BAX:US $ 252M 181M
Bristol Myers Squibb BMY:US $ 1421M 143M
Clovis Oncology CLVS:US $ -71.33M 11.16M
Eli Lilly And LLY:US $ 952.5M 950.4M
Enanta Pharmaceuticals ENTA:US $ -31.7M 1.89M
Endo International Ordinary Shares ENDP:US $ -1885.43M 1813.45M
Gilead Sciences GILD:US $ 1144M 1125M
GlaxoSmithKline GSK:LN 83800M 96400M
Glaxosmithkline GSK:US $ 838M 964M
Harsco HSC:US $ -105.59M 65.75M
Immunogen IMGN:US $ -62.02M 37.88M
Insmed INSM:US $ -95645000 1.02M
Karyopharm Therapeutics KPTI:US $ -49062000 7.66M
Lannett LCI:US $ -93.3M 58.4M
Macrogenics MGNX:US $ -41.3M 25.14M
Merk MRK:US $ 3944M 366M
Pacira Pharmaceuticals PCRX:US $ 19.88M 13.05M
Pfizer PFE:US $ 9905M 2042M
Rigel Pharmaceuticals RIGL:US $ -13.49M 13.95M
Sangamo Biosciences SGMO:US $ -43.17M 0.8M
Spectrum Pharmaceuticals SPPI:US $ -29.05M 13.61M
Teva Pharmaceutical Industries TEVA:US $ -233M 722M
Veracyte VCYT:US $ -9.53M 4.93M